Detalhe da pesquisa
1.
Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer.
Nature
; 608(7921): 199-208, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35859180
2.
TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell Tumors.
Oncologist
; 27(11): e912-e915, 2022 11 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36166584
3.
A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes.
NPJ Precis Oncol
; 7(1): 27, 2023 Mar 13.
Artigo
Inglês
| MEDLINE | ID: mdl-36914848
4.
Somatic Features of Response and Relapse in Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin Immunotherapy.
Eur Urol Oncol
; 5(6): 677-686, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34895867
5.
Plasma Circulating Tumor DNA and Clonal Hematopoiesis in Metastatic Renal Cell Carcinoma.
Clin Genitourin Cancer
; 18(4): 322-331.e2, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32046920
6.
Immunocytochemistry for ARID1A as a potential biomarker in urine cytology of bladder cancer.
Cancer Cytopathol
; 127(9): 578-585, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-31386310
7.
Frequent mutation of the FOXA1 untranslated region in prostate cancer.
Commun Biol
; 1: 122, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30272002